Phosphoinositide 3-kinase inhibitors, including idelalisib, overcome P-glycoprotein-mediated resistance to gemtuzumab ozogamicin in human acute myeloid leukemia cells

Authors :: Roland B. Walter
George S. Laszlo
Colin D. Godwin
Olivia M. Bates
Source :: Clinical Lymphoma Myeloma and Leukemia. 17:S291
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Cancer Research
Phosphoinositide 3-kinase
biology
business.industry
Gemtuzumab ozogamicin
Myeloid leukemia
Hematology
Oncology
Cancer research
biology.protein
Medicine
business
Idelalisib
medicine.drug
P-glycoprotein

Full Text Access

Tools